Princeton, NJ – Taiho Oncology has announced the appointment of Peter Melnyk as President and Chief Executive Officer. About Taiho Oncology: The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development and commercialization of orally administered anti-cancer agents for various tumor types. Taiho Oncology has a robust pipeline of small molecule clinical candidates targeting solid tumor and hematological malignancies, with additional candidates in pre-clinical development. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent companys European and Canadian operations, which are located in Baar, Switzerland and Oakville, Ontario, Canada.

For more information on Taiho Oncology please visit:

Website: https://www.taihooncology.com/
LinkedIn Page: https://www.linkedin.com/company/taiho-oncology-inc/

Taiho Oncology
101 Carnegie Center Suite 101
Princeton, NJ 8540
Phone: 609-750-5300

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved